The Revolutionary Treatment That Could End Sleep Apnea Forever

Breakthrough Treatment for Obstructive Sleep Apnea: FDA Approves Zepbound (Tirzepatide) #kundlasmd #shieldmedicalgroup In this video, Dr. Kulmeet kundlas discusses a major medical advancement in the treatment of obstructive sleep apnea—the FDA's approval of tirzepatide, marketed as Zepbound, in December 2024. He highlights the significant impact of sleep apnea and the limitations of traditional treatments like CPAP machines. Dr. explains how Zepbound not only treats but may cure sleep apnea by addressing underlying metabolic issues, helping patients lose weight, and improving overall health. He also covers the pathophysiology, diagnosis, risk factors, and alternative treatments for obstructive sleep apnea, emphasizing the vital role of a healthy lifestyle. Stay tuned for the latest updates and evidence-based solutions to manage and potentially cure this condition.